Drug Profile


Alternative Names: Ganaton; HSR 803; Itax

Latest Information Update: 13 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Abbott Japan
  • Developer Abbott Japan; AbbVie; Astellas Pharma; Axcan Pharma
  • Class Antiulcers; Benzamides; Benzyl compounds; Gastrokinetics; Small molecules
  • Mechanism of Action Dopamine D2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Gastritis; Gastrointestinal disorders
  • Discontinued Diabetic gastroparesis; Non-ulcer dyspepsia; Postoperative ileus

Most Recent Events

  • 13 Feb 2017 CTP push 281683 - Trial completion info already updated; Minor updates done in KDM
  • 03 Feb 2014 Aptalis has been acquired by Forest Laboratories
  • 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top